CHRONIC UVEITIS is a serious complication of juvenile rheumatoid arthritis
(JRA). Approximately 6% of all cases of uveitis occur in children,1 and up to 80% of all cases of anterior uveitis in
childhood are associated with JRA.2 Although
remarkable progress has been made in the care of patients with JRA-associated
uveitis since the development of corticosteroids for systemic and ophthalmic
use in the 1950s, up to 12% of children with uveitis associated with pauciarticular
JRA still develop permanent blindness as a result of low-grade chronic intraocular
inflammation.3 Ironically, these children are
often under careful observation by ophthalmologists who may opt to tolerate
low-grade ocular inflammation, hoping to avoid the development of corticosteroid-induced
ocular adverse effects such as cataracts and glaucoma.4
The vision-robbing consequences of low-grade uveitis occur extremely slowly,
typically over a period of 4 to 8 years, and the end result is clear: even
low-grade uveitis may lead eventually to ocular damage, including band keratopathy,
maculopathy (macular edema, macular cysts, epiretinal membrane), glaucomatous
optic neuropathy, and cataract formation from chronic inflammation and corticosteroid
surgical treatment of cataract and glaucoma is remarkably successful in the
general population, it is consistently less so in patients with JRA-associated
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 13
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.